Home / Inspections / 960658

FDA Inspection 960658 — Stason Pharmaceuticals, Inc.

Stason Pharmaceuticals, Inc. — FEI 1000160561

The FDA completed an inspection of Stason Pharmaceuticals, Inc. on March 8, 2016 in Irvine, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 8, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Irvine, CA (United States)

Facility

Other inspections at this facility

  • 1140029 (VAI Tue Apr 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1109969 (OAI Fri Oct 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1067952 (NAI Fri Aug 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 911418 (VAI Thu Jan 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 859439 (VAI Wed Dec 18 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources